Announced Tue, 28 Oct · 12:57 IST

Lincoln Pharmaceuticals Limited has informed the Exchange regarding Minutes of Annual General Meeting held on September 30, 2025.

Board & Shareholder Meetings View source PDF

LINCOLN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Lincoln Pharmaceuticals Limited has submitted the minutes of its Annual General Meeting (AGM) held on September 30, 2025, to the stock exchange. This is a routine regulatory disclosure required after an AGM is concluded. The minutes typically include details of business transacted, resolutions passed, and any approvals granted by shareholders during the meeting.

Likely market impact

This is a standard post-AGM compliance filing and is unlikely to have a material impact on the stock price. Investors should review the attached minutes for any key resolutions, business updates, or management commentary disclosed during the meeting.